Time to Admission in Acute Ischemic Stroke and Transient Ischemic Attack
نویسندگان
چکیده
منابع مشابه
Time to admission in acute ischemic stroke and transient ischemic attack.
BACKGROUND AND PURPOSE The effect of thrombolysis depends on the time from stroke onset to treatment and therefore also on the time when patients come to the hospital. This study was designed to analyze the variables that influence the time from symptom onset to admission (TTA) to the stroke unit. METHODS We evaluated the medical records of 615 consecutive stroke or transient ischemic attack ...
متن کامل100 - Transient Ischemic Attack and Acute Ischemic Stroke
The yearly incidence of TIA in the United States has been estimated to be approximately 200,000 to 500,000 but may be higher because of the high frequency of underreporting of these events by medical professionals. The annual incidence of TIA may be less and the annual incidence of stroke may be higher if the tissue-based definition were applied to all patients evaluated for TIA. It has been es...
متن کاملdysphagia in acute ischemic stroke
Introduction: Swallowing dysfunction complicates acute strokes in 25-32% of cases and directly affects patientschr('39') prognosis and recovery. Dysphagia complicates the course of acute strokes through its potential of the development of chest infection, nutritional problems, and dehydration. Dysphagia is also an independent predictor of respiratory morbidity and mortality in acute stroke. In...
متن کاملTowards precision medicine in ischemic stroke and transient ischemic attack.
Although there is no consensus on the exact definition of precision medicine, it is generally agreed upon that the term entails diagnosis and therapy tailored to the individual patient. Precision medicine has seen major advances in the past two decades, many of which are relevant to ischemic stroke or transient ischemic attack (TIA). Advances include substantial improvements in high-throughput ...
متن کاملTicagrelor versus Aspirin in Acute Stroke or Transient Ischemic Attack.
BACKGROUND Ticagrelor may be a more effective antiplatelet therapy than aspirin for the prevention of recurrent stroke and cardiovascular events in patients with acute cerebral ischemia. METHODS We conducted an international double-blind, controlled trial in 674 centers in 33 countries, in which 13,199 patients with a nonsevere ischemic stroke or high-risk transient ischemic attack who had no...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Stroke
سال: 2006
ISSN: 0039-2499,1524-4628
DOI: 10.1161/01.str.0000206546.76860.6b